Stockreport

Monopar Therapeutics to Present at Upcoming Investor Conferences in September

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing [Read more]